Day : September 27, 2018


DEA Gives CBD Derived Pharmaceutical, Epidiolex, Approval as a Schedule V Drug

The Drug Enforcement Administration (DEA) has given the Cannabidiol (CBD) derived pharmaceutical product, Epidiolex, a reported Schedule V status. The newly approved drug is an oral solution that is used for the reduction of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. The CBD product Epidiolex is derived from the cannabis...

Cash Crop Today 420 Real Properties Interview with Matthew Thompson

The company 420 Real Properties specializes in finding 420 friendly, commercial cannabis properties for lease and purchase. Their company offers listing services for property owners as well as property search services for cultivators, manufacturers, distributors, retailers and testing professionals. Their clientele generally consists of seasoned industry veterans, entrepreneurs, and new business owners who are...